EphA2-positive human umbilical cord-derived mesenchymal stem cells exert anti-fibrosis and immunomodulatory activities via secretion of prostaglandin E2

Objective: Previous study has demonstrated that EphA2 is a biomarker of mesenchymal stem cells (MSCs) from human placenta or umbilical cord and is able to distinguish MSCs from fibroblasts. In this study, we further examine the potential efficacy of EphA2+ human umbilical cord-derived MSCs (hUC-MSCs...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu-Chieh Wen (Author), Mao-Kuang Du (Author), Meng-Wei Li (Author), Yogi Cheng-Yo Hsuan (Author), Yu-Chin Su (Author), Willie Lin (Author)
Format: Book
Published: Elsevier, 2018-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_b4d5cd13af6e4041a31cde00367699e1
042 |a dc 
100 1 0 |a Yu-Chieh Wen  |e author 
700 1 0 |a Mao-Kuang Du  |e author 
700 1 0 |a Meng-Wei Li  |e author 
700 1 0 |a Yogi Cheng-Yo Hsuan  |e author 
700 1 0 |a Yu-Chin Su  |e author 
700 1 0 |a Willie Lin  |e author 
245 0 0 |a EphA2-positive human umbilical cord-derived mesenchymal stem cells exert anti-fibrosis and immunomodulatory activities via secretion of prostaglandin E2 
260 |b Elsevier,   |c 2018-10-01T00:00:00Z. 
500 |a 1028-4559 
500 |a 10.1016/j.tjog.2018.08.020 
520 |a Objective: Previous study has demonstrated that EphA2 is a biomarker of mesenchymal stem cells (MSCs) from human placenta or umbilical cord and is able to distinguish MSCs from fibroblasts. In this study, we further examine the potential efficacy of EphA2+ human umbilical cord-derived MSCs (hUC-MSCs). Materials and methods: MSCs specific markers, EphA2 and CD146 expression on the surface of hUC-MSCs were determined by flow cytometry analysis. Quantitative real time polymerase chain reaction was used to examine pro-fibrotic gene expression of TGF-β1-stimulated lung fibroblast (MRC-5 cells). On the other hand, ELISA was used to analyze the content of pro-inflammatory cytokines (TNF-ɑ; and IP-10) in the LPS-activated macrophages culture supernatant. Results: The pro-fibrotic gene (TGF-β1, CTGF, fibronectin, collagen I and TIMP-1) expression in TGF-β1-activated MRC-5 cells and the pro-inflammatory cytokines (TNF-ɑ and IP-10) in the LPS-activated macrophages culture supernatant were both attenuated when in present of EphA2+ hUC-MSCs. Moreover, once EphA2+ hUC-MSCs treated with prostaglandin E2 specific inhibitor NS-398, both anti-fibrotic and anti-inflammatory effects of EphA2+ hUC-MSCs were abolished. Conclusion: EphA2+ hUC-MSCs possess immunomodulatory and anti-fibrotic properties, and PGE2 plays an important role in these activities. This implies that EphA2+ hUC-MSCs have potentially effectiveness for treatment of acute inflammatory and chronic fibrotic lung diseases. Keywords: Anti-fibrosis, EphA2, Immunomodulatory, Mesenchymal stem cells, Prostaglandin E2 
546 |a EN 
690 |a Gynecology and obstetrics 
690 |a RG1-991 
655 7 |a article  |2 local 
786 0 |n Taiwanese Journal of Obstetrics & Gynecology, Vol 57, Iss 5, Pp 722-725 (2018) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S1028455918301876 
787 0 |n https://doaj.org/toc/1028-4559 
856 4 1 |u https://doaj.org/article/b4d5cd13af6e4041a31cde00367699e1  |z Connect to this object online.